Physician

Kathe S Bryson, M.D.

According to 2025 Medicare claims, Kathe Bryson, M.D. (NPI: 1043206303) practices rheumatology in the Erie, PA market, with the plurality of this provider's patient population coming from Erie, PA. This provider's primary affiliated billing organization is ARTHRITIS ASSOCIATES (NPI: 1023072352; TIN: 251693042) and primary practice location at 16508-2558.

Bryson's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 559 traditional Medicare patients, billed 132,420 HCPCS/CPT codes, and received $1,092,110 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 4,471 prescription claims across 585 beneficiaries totaling $2,286,622 in drug costs, led by Enbrel Sureclick (Etanercept). Open Payments data shows 90 records totaling $1,530. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $64,411 to $1,092,110. Similarly, Part D prescription costs have risen steadily, from $1,455,924 to $2,286,622. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	413	1,111	$64,411
2016	409	4,944	$85,968
2017	404	7,461	$98,194
2018	384	13,940	$256,105
2019	369	43,517	$537,945
2020	347	51,303	$536,838
2021	476	71,228	$761,150
2022	582	121,239	$1,054,532
2023	558	132,266	$1,088,483
2024	559	132,420	$1,092,110

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	495	4,465	$1,455,924
2016	508	4,274	$1,664,402
2017	482	4,030	$1,777,932
2018	474	3,977	$1,903,262
2019	477	3,975	$1,828,698
2020	486	4,071	$1,676,042
2021	583	4,179	$2,331,617
2022	669	4,501	$2,466,858
2023	648	4,767	$2,405,595
2024	585	4,471	$2,286,622

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	328	629	$84
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	260	378	$57
96365	Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less	68	295	$46
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	383	690	$12
96372	Injection of drug or substance under skin or into muscle	86	293	$10

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Enbrel Sureclick	Etanercept	48	1,344	$350,437
Humira(Cf) Pen	Adalimumab	28	840	$278,044
Enbrel	Etanercept	30	840	$213,813
Humira	Adalimumab	26	728	$176,005
Gamunex-C	Immune Globul G/Gly/Iga Avg 46	22	660	$161,251

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	90	$1,530	Janssen Biotech, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Kathe S. Bryson, M.D.?

Tedicare shows public-source Medicare data for Kathe S. Bryson, M.D. (NPI 1043206303), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Kathe S. Bryson, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Kathe S. Bryson, M.D.?

Kathe S. Bryson, M.D. is linked to ARTHRITIS ASSOCIATES (billing NPI 1023072352) in the available physician profile data.

Does Kathe S. Bryson, M.D. have Open Payments data?

Kathe S. Bryson, M.D. has 90 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.